The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-Bank rules force staff to turn off NHS COVID-19 tracing app at work

Thu, 08th Oct 2020 13:32

* Thousands of staff seen at risk of undetected infection -
union

* Some banks ask staff to store phones away to prevent data
leaks

* Govt advises NHS app should be paused if phone not on
person
(Adds TSB comment)

By Iain Withers and Sinead Cruise

LONDON, Oct 8 (Reuters) - Branch staff at some of Britain's
biggest banks say rules that require them to store phones in
lockers while at work are putting them at undue risk of COVID-19
from colleagues and customers, as they cannot use the country's
tracing app.

Lloyds Banking Group, along with rival TSB, are
among those advising employees to deactivate the NHS Track &
Trace app during office hours, when they are not allowed to keep
phones on their person.

Some banks ask staff and cashiers to store phones away to
prevent leaks of sensitive customer data, although this is not
formally required by regulator the Financial Conduct Authority.

Under current government guidelines, users of the NHS app
are advised to disable bluetooth or pause the app when away from
their phones to avoid false notifications.

Other companies have told staff to pause the app at work,
including pharmaceuticals firm GSK, which said its other
safety measures were sufficient, the Guardian newspaper
reported.

The BTU union, which represents staff working for Lloyds but
is not recognised by the bank, said it had been contacted by
dozens of staff unable to use the app, which has been downloaded
by more than 14 million people.

One unnamed Lloyds employee who contacted the BTU said: "I
live and work in a high-risk area so I am very concerned at
being told that while I'm at work I have to suspend the NHS test
and trace app... This defeats the object of track and trace."

Another said they were at risk as they had to conduct
face-to-face meetings and due to the "blatant transgression of
the social distancing rules by many customers".

"Customers and staff have a right to know if they have come
into contact with someone who's been infected," said Mark Brown,
general secretary of the BTU.

Although several European countries have launched
Bluetooth-based apps to alert those at risk of catching
COVID-19, there is little evidence to date that the technology
has significantly curbed infections.

Both Lloyds and TSB have advised staff to pause the app's
tracing function while at work, according to internal guidance
issued by each lender seen by Reuters.

"Colleagues who have downloaded the app to their own smart
phone should not use the app while you are at work," Lloyds told
staff, adding it was to stop people receiving false alerts.

A NatWest spokesman said the bank encouraged staff to use
the app but said they should pause it when they are not with
their phone. The bank discourages - though doesn't ban - the use
of personal phones in branches and contact centres.

A spokesman for Barclays said the bank had not advised staff
to turn off the app.

A Department of Health and Social Care spokeswoman said: "We
want as many people to download and use the app as possible. It
is important to use the NHS Covid-19 app at all times, including
while at work, unless in specific scenarios which are clearly
set out in our guidance."

A spokeswoman for TSB said: "We're fully complying with all
public health guidance and advising our colleagues in line with
best practice."

Lloyds declined to comment.

A second employee union, Accord, said rules prohibiting use
of personal phones in the workplace were in place to protect
employees from security risks.

"If customers care about the health and well-being of the
bank staff they rely on, they could help by wearing face
coverings when visiting bank branches," Accord's General
Secretary Ged Nichols said.
(Reporting by Iain Withers and Sinead Cruise; Additional
reporting by Douglas Busvine in Berlin; Editing by Rachel
Armstrong, Jan Harvey and Elaine Hardcastle)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.